Lung Ultrasound in Comparison With C.T in Covid-19

Can Lung Ultrasound Play a Competitive Role With Computed Tomography in Diagnosis and Follow up of Covid-19 Patients?

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05158803

Enrollment

200

Registered

2021-12-15

Start date

2022-01-01

Completion date

2024-12-30

Last updated

2021-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Brief summary

investigate the diagnostic ability of thoracic ultrasound in suspicious COVID-19 infection and/or COVID-19 pneumonia. Also, to compare its findings to CT and follow up these findings.

Detailed description

ultrasound and C.T will be assessed in acute presentation of Covid 19 patients and then those patients will be reassessed again after 1 month by lung ultrasound and C.T and if ultrasound will show the same efficacy of diagnosis or not

Interventions

RADIATIONultrasound and C.T

lung ultrasound in comparison to C.T

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 95 Years

Healthy volunteers

Inclusion criteria

* all cases of covid 19 patients

Exclusion criteria

* all other causes of consolidation ,ground glass fibrosis or collapse findings of C.T and ultrasound

Design outcomes

Primary

Measure	Time frame	Description
diagnostic ability of thoracic ultrasound for diagnosis and follow up of covid19 patients	after 1 month of acute presentation	compare lung ultrasound with C.T finding of covid 19 patients

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026